Correlation Between Inhibrx and 04685A3F6
Specify exactly 2 symbols:
By analyzing existing cross correlation between Inhibrx and ATH 1716 07 JAN 25, you can compare the effects of market volatilities on Inhibrx and 04685A3F6 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of 04685A3F6. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and 04685A3F6.
Diversification Opportunities for Inhibrx and 04685A3F6
Good diversification
The 3 months correlation between Inhibrx and 04685A3F6 is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and ATH 1716 07 JAN 25 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATH 1716 07 and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with 04685A3F6. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATH 1716 07 has no effect on the direction of Inhibrx i.e., Inhibrx and 04685A3F6 go up and down completely randomly.
Pair Corralation between Inhibrx and 04685A3F6
Given the investment horizon of 90 days Inhibrx is expected to generate 0.92 times more return on investment than 04685A3F6. However, Inhibrx is 1.09 times less risky than 04685A3F6. It trades about 0.0 of its potential returns per unit of risk. ATH 1716 07 JAN 25 is currently generating about -0.29 per unit of risk. If you would invest 1,512 in Inhibrx on October 12, 2024 and sell it today you would lose (14.00) from holding Inhibrx or give up 0.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 40.0% |
Values | Daily Returns |
Inhibrx vs. ATH 1716 07 JAN 25
Performance |
Timeline |
Inhibrx |
ATH 1716 07 |
Inhibrx and 04685A3F6 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and 04685A3F6
The main advantage of trading using opposite Inhibrx and 04685A3F6 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, 04685A3F6 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 04685A3F6 will offset losses from the drop in 04685A3F6's long position.Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
04685A3F6 vs. Inhibrx | 04685A3F6 vs. Sellas Life Sciences | 04685A3F6 vs. Summit Therapeutics PLC | 04685A3F6 vs. Codexis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |